Cambridge, United Kingdom

John Charles Reader

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 366(Granted Patents)


Location History:

  • Cambridge, GB (2005 - 2021)
  • Linton, GB (2010 - 2023)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Innovations of John Charles Reader in Pharmaceutical Chemistry

Introduction

John Charles Reader, based in Cambridge, GB, is a prominent inventor known for his significant contributions to the field of pharmaceutical chemistry, particularly in the development of TYK2 kinase inhibitors. With a remarkable portfolio of 19 patents, he has made strides in creating compounds that address critical medical needs.

Latest Patents

Among his latest innovations, Reader has developed TYK2 kinase inhibitors that offer potential treatments for inflammatory and immune disorders. His invention includes compounds characterized by the formula (1) or its derivatives, which also encompasses pharmaceutical compositions for medical use. Furthermore, he has devised a method of inhibiting TYK2 kinase that involves using a compound represented by the formula (0). This encompasses a novel subset of compounds and their corresponding pharmaceutical applications, showcasing Reader's dedication to advancing medical science.

Career Highlights

Reader has worked with reputable organizations throughout his career, including Cancer Research Technology Limited and Sareum Limited. His involvement in these companies illustrates his commitment to translating scientific advancements into viable therapeutic solutions.

Collaborations

Collaboration is key in innovation, and Reader has worked alongside notable colleagues such as Michael Cherry and Ian James Collins, further enhancing the scope and impact of his research and inventions.

Conclusion

John Charles Reader's contributions to pharmaceutical innovations, particularly in the area of TYK2 kinase inhibitors, underline his role as a leading inventor in the industry. His ongoing work reflects not only his dedication to research but also his commitment to improving healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…